Commerce Bank’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.76M | Buy |
14,538
+510
| +4% | +$95.9K | 0.01% | 494 |
|
|
2026
Q1 | $2.77M | Buy |
14,028
+575
| +4% | +$111K | 0.01% | 466 |
|
|
2025
Q4 | $2.47M | Buy |
13,453
+1,162
| +9% | +$204K | 0.01% | 447 |
|
|
2025
Q3 | $1.89M | Buy |
12,291
+2,427
| +25% | +$367K | 0.01% | 512 |
|
|
2025
Q2 | $1.38M | Buy |
9,864
+52
| +0.5% | +$7.29K | 0.01% | 572 |
|
|
2025
Q1 | $1.44M | Sell |
9,812
-475
| -5% | -$68.7K | 0.01% | 537 |
|
|
2024
Q4 | $1.35M | Buy |
10,287
+580
| +6% | +$81.2K | 0.01% | 549 |
|
|
2024
Q3 | $1.51M | Buy |
9,707
+566
| +6% | +$91.4K | 0.01% | 536 |
|
|
2024
Q2 | $1.43M | Sell |
9,141
-280
| -3% | -$42.1K | 0.01% | 529 |
|
|
2024
Q1 | $1.28M | Buy |
9,421
+109
| +1% | +$14.4K | 0.01% | 569 |
|
|
2023
Q4 | $1.25M | Sell |
9,312
-1,101
| -11% | -$143K | 0.01% | 556 |
|
|
2023
Q3 | $1.41M | Buy |
10,413
+583
| +6% | +$79.6K | 0.01% | 506 |
|
|
2023
Q2 | $1.41M | Sell |
9,830
-40
| -0.4% | -$5.88K | 0.01% | 514 |
|
|
2023
Q1 | $1.37M | Buy |
9,870
+1,170
| +13% | +$157K | 0.01% | 504 |
|
|
2022
Q4 | $1.18M | Sell |
8,700
-466
| -5% | -$58.4K | 0.01% | 526 |
|
|
2022
Q3 | $1.01M | Buy |
9,166
+144
| +2% | +$18.3K | 0.01% | 548 |
|
|
2022
Q2 | $1.19M | Sell |
9,022
-685
| -7% | -$89.9K | 0.01% | 529 |
|
|
2022
Q1 | $1.29M | Buy |
9,707
+111
| +1% | +$13.3K | 0.01% | 543 |
|
|
2021
Q4 | $1.12M | Sell |
9,596
-1,357
| -12% | -$160K | 0.01% | 600 |
|
|
2021
Q3 | $1.32M | Buy |
10,953
+5,668
| +107% | +$660K | 0.01% | 552 |
|
|
2021
Q2 | $633K | Sell |
5,285
-461
| -8% | -$50.6K | ﹤0.01% | 740 |
|
|
2021
Q1 | $572K | Buy |
5,746
+1,493
| +35% | +$150K | ﹤0.01% | 761 |
|
|
2020
Q4 | $425K | Sell |
4,253
-499
| -11% | -$52.9K | ﹤0.01% | 835 |
|
|
2020
Q3 | $520K | Buy |
4,752
+189
| +4% | +$21K | ﹤0.01% | 673 |
|
|
2020
Q2 | $482K | Buy |
4,563
+225
| +5% | +$23.2K | ﹤0.01% | 674 |
|
|
2020
Q1 | $388K | Sell |
4,338
-41
| -0.9% | -$3.86K | ﹤0.01% | 666 |
|
|
2019
Q4 | $437K | Buy |
4,379
+130
| +3% | +$12.2K | ﹤0.01% | 689 |
|
|
2019
Q3 | $379K | Sell |
4,249
-603
| -12% | -$52.3K | ﹤0.01% | 703 |
|
|
2019
Q2 | $400K | Sell |
4,852
-25
| -0.5% | -$1.96K | ﹤0.01% | 677 |
|
|
2019
Q1 | $395K | Buy |
4,877
+794
| +19% | +$62.6K | ﹤0.01% | 637 |
|
|
2018
Q4 | $310K | Sell |
4,083
-89
| -2% | -$6.95K | ﹤0.01% | 680 |
|
|
2018
Q3 | $330K | Sell |
4,172
-891
| -18% | -$67.4K | ﹤0.01% | 709 |
|
|
2018
Q2 | $356K | Buy |
5,063
+90
| +2% | +$6.47K | ﹤0.01% | 679 |
|
|
2018
Q1 | $347K | Sell |
4,973
-801
| -14% | -$55.5K | ﹤0.01% | 673 |
|
|
2017
Q4 | $400K | Buy |
5,774
+740
| +15% | +$49.9K | 0.01% | 637 |
|
|
2017
Q3 | $341K | Sell |
5,034
-312
| -6% | -$19.7K | ﹤0.01% | 670 |
|
|
2017
Q2 | $365K | Hold |
5,346
| – | – | 0.01% | 625 |
|
|
2017
Q1 | $333K | Sell |
5,346
-403
| -7% | -$23.5K | ﹤0.01% | 642 |
|
|
2016
Q4 | $314K | Buy |
5,749
+15
| +0.3% | +$852 | ﹤0.01% | 635 |
|
|
2016
Q3 | $376K | Sell |
5,734
-350
| -6% | -$22.9K | 0.01% | 580 |
|
|
2016
Q2 | $367K | Sell |
6,084
-150
| -2% | -$8.71K | 0.01% | 581 |
|
|
2016
Q1 | $351K | Hold |
6,234
| – | – | 0.01% | 596 |
|
|
2015
Q4 | $424K | Sell |
6,234
-685
| -10% | -$44.9K | 0.01% | 534 |
|
|
2015
Q3 | $440K | Sell |
6,919
-430
| -6% | -$28.3K | 0.01% | 527 |
|
|
2015
Q2 | $468K | Buy |
7,349
+363
| +5% | +$24.9K | 0.01% | 545 |
|
|
2015
Q1 | $478K | Hold |
6,986
| – | – | 0.01% | 545 |
|
|
2014
Q4 | $491K | Hold |
6,986
| – | – | 0.01% | 540 |
|
|
2014
Q3 | $499K | Sell |
6,986
-848
| -11% | -$62.1K | 0.01% | 513 |
|
|
2014
Q2 | $582K | Sell |
7,834
-4,130
| -35% | -$299K | 0.01% | 484 |
|
|
2014
Q1 | $776K | Sell |
11,964
-88
| -0.7% | -$5.68K | 0.01% | 422 |
|
|
2013
Q4 | $715K | Buy |
12,052
+1,112
| +10% | +$60.4K | 0.01% | 432 |
|
|
2013
Q3 | $568K | Sell |
10,940
-1,095
| -9% | -$55K | 0.01% | 447 |
|
|
2013
Q2 | $570K | Buy |
+12,035
| New | +$613K | 0.01% | 433 |
|
Other funds holding AZN
EP
IA
Commerce Bank's AZN Position: Q2 2026 in Review
Commerce Bank increased its AstraZeneca (AZN) stake by 3.6% in Q2 2026, buying an estimated $95.9K and bringing the position to 14,538 shares worth $2.76M. The position accounts for 0.01% of the portfolio, ranked #494.
Commerce Bank first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.77M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Commerce Bank held 14,538 shares of AstraZeneca worth $2.76M as of Q2 2026.
- Commerce Bank bought 510 AstraZeneca shares in Q2 2026, an estimated $95.9K.
- AstraZeneca made up 0.01% of Commerce Bank's portfolio in Q2 2026, its #494 holding.
- Commerce Bank first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- Commerce Bank's AstraZeneca position peaked at $2.77M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.